1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Introduction
2.2. Define: Research Objective
2.3. Determine: Research Design
2.4. Prepare: Research Instrument
2.5. Collect: Data Source
2.6. Analyze: Data Interpretation
2.7. Formulate: Data Verification
2.8. Publish: Research Report
2.9. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing demand for vaccines leading to capacity expansion by contract manufacturers
5.1.1.2. Paradigm shift toward cell-based vaccine production
5.1.1.3. Key advantages such as cost and time saving offered by contract services
5.1.1.4. Vaccination coverage across the globe
5.1.2. Restraints
5.1.2.1. Limited outsourcing by well-established vaccine manufacturers
5.1.3. Opportunities
5.1.3.1. Rising global demand to cater to the growing population of varied age groups
5.1.3.2. Innovation and robust vaccine pipeline
5.1.3.3. Favorable government insights and guidelines to speed up the vaccine manufacturing
5.1.4. Challenges
5.1.4.1. Pharma companies manufacturing operations in-house to gain strategic control
5.2. Cumulative Impact of COVID-19

6. Vaccine Contract Manufacturing Market, by Function
6.1. Introduction
6.2. Downstream
6.2.1. Analytical & QC studies
6.2.2. Fill & Finish Operations
6.2.3. Packaging
6.3. Upstream
6.3.1. Bacterial Expression Systems
6.3.2. Baculovirus/Insect Expression Systems
6.3.3. Mammalian Expression Systems
6.3.4. Yeast Expression Systems

7. Vaccine Contract Manufacturing Market, by Type
7.1. Introduction
7.2. Attenuated Vaccine
7.3. DNA Vaccines
7.4. Inactivated Vaccine
7.5. Subunit Vaccines
7.6. Toxoid Vaccines

8. Vaccine Contract Manufacturing Market, by Applications
8.1. Introduction
8.2. Human Use
8.3. Veterinary

9. Americas Vaccine Contract Manufacturing Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Vaccine Contract Manufacturing Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand

11. Europe, Middle East & Africa Vaccine Contract Manufacturing Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. Ajinomoto Althea, Inc.
13.2. Albany Molecular Research, Inc.
13.3. Catalent, Inc.
13.4. Cobra Bio
13.5. Cytovance Biologics
13.6. FUJIFILM Diosynth Biotechnologies
13.7. GlaxoSmithKline PLC
13.8. ICON PLC
13.9. IDT Biologika
13.10. KBI Biopharma
13.11. LONZA
13.12. Merck KGaA
13.13. Paragon Bioservices, Inc.
13.14. Pfizer, Inc.
13.15. Pharmaceutical Product Development, LLC
13.16. PRA Health Sciences

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing

List of Figures

FIGURE 1. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET: MARKET DYNAMICS
FIGURE 3. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2020 VS 2027 (%)
FIGURE 4. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2020 VS 2027 (USD MILLION)
FIGURE 5. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2027
FIGURE 6. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2027 (USD MILLION)
FIGURE 7. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 8. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL & QC STUDIES, 2018-2027 (USD MILLION)
FIGURE 9. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL & QC STUDIES, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 10. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FILL & FINISH OPERATIONS, 2018-2027 (USD MILLION)
FIGURE 11. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FILL & FINISH OPERATIONS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 12. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY PACKAGING, 2018-2027 (USD MILLION)
FIGURE 13. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY PACKAGING, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 14. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2027 (USD MILLION)
FIGURE 15. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 16. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY BACTERIAL EXPRESSION SYSTEMS, 2018-2027 (USD MILLION)
FIGURE 17. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY BACTERIAL EXPRESSION SYSTEMS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 18. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY BACULOVIRUS/INSECT EXPRESSION SYSTEMS, 2018-2027 (USD MILLION)
FIGURE 19. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY BACULOVIRUS/INSECT EXPRESSION SYSTEMS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 20. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY MAMMALIAN EXPRESSION SYSTEMS, 2018-2027 (USD MILLION)
FIGURE 21. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY MAMMALIAN EXPRESSION SYSTEMS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 22. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY YEAST EXPRESSION SYSTEMS, 2018-2027 (USD MILLION)
FIGURE 23. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY YEAST EXPRESSION SYSTEMS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 24. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2020 VS 2027 (%)
FIGURE 25. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2020 VS 2027 (USD MILLION)
FIGURE 26. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2027
FIGURE 27. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY ATTENUATED VACCINE, 2018-2027 (USD MILLION)
FIGURE 28. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY ATTENUATED VACCINE, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 29. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DNA VACCINES, 2018-2027 (USD MILLION)
FIGURE 30. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DNA VACCINES, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 31. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY INACTIVATED VACCINE, 2018-2027 (USD MILLION)
FIGURE 32. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY INACTIVATED VACCINE, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 33. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY SUBUNIT VACCINES, 2018-2027 (USD MILLION)
FIGURE 34. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY SUBUNIT VACCINES, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 35. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TOXOID VACCINES, 2018-2027 (USD MILLION)
FIGURE 36. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TOXOID VACCINES, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 37. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2020 VS 2027 (%)
FIGURE 38. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2020 VS 2027 (USD MILLION)
FIGURE 39. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2027
FIGURE 40. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY HUMAN USE, 2018-2027 (USD MILLION)
FIGURE 41. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY HUMAN USE, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 42. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY VETERINARY, 2018-2027 (USD MILLION)
FIGURE 43. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY VETERINARY, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 44. AMERICAS VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 45. ARGENTINA VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 46. BRAZIL VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 47. CANADA VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 48. MEXICO VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 49. UNITED STATES VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 50. ASIA-PACIFIC VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 51. AUSTRALIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 52. CHINA VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 53. INDIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 54. INDONESIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 55. JAPAN VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 56. MALAYSIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 57. PHILIPPINES VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 58. SINGAPORE VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 59. SOUTH KOREA VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 60. TAIWAN VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 61. THAILAND VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 62. EUROPE, MIDDLE EAST & AFRICA VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 63. FRANCE VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 64. GERMANY VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 65. ITALY VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 66. NETHERLANDS VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 67. QATAR VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 68. RUSSIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 69. SAUDI ARABIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 70. SOUTH AFRICA VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 71. SPAIN VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 72. UNITED ARAB EMIRATES VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 73. UNITED KINGDOM VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 74. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET: FPNV POSITIONING MATRIX
FIGURE 75. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 76. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL VACCINE CONTRACT MANUFACTURING MARKET, BY TYPE

List of Tables

TABLE 1. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2027 (USD MILLION)
TABLE 4. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, BY REGION, 2018-2027 (USD MILLION)
TABLE 5. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL & QC STUDIES, BY REGION, 2018-2027 (USD MILLION)
TABLE 6. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FILL & FINISH OPERATIONS, BY REGION, 2018-2027 (USD MILLION)
TABLE 7. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY PACKAGING, BY REGION, 2018-2027 (USD MILLION)
TABLE 8. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, BY REGION, 2018-2027 (USD MILLION)
TABLE 9. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY BACTERIAL EXPRESSION SYSTEMS, BY REGION, 2018-2027 (USD MILLION)
TABLE 10. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY BACULOVIRUS/INSECT EXPRESSION SYSTEMS, BY REGION, 2018-2027 (USD MILLION)
TABLE 11. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY MAMMALIAN EXPRESSION SYSTEMS, BY REGION, 2018-2027 (USD MILLION)
TABLE 12. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY YEAST EXPRESSION SYSTEMS, BY REGION, 2018-2027 (USD MILLION)
TABLE 13. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 14. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY ATTENUATED VACCINE, BY REGION, 2018-2027 (USD MILLION)
TABLE 15. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DNA VACCINES, BY REGION, 2018-2027 (USD MILLION)
TABLE 16. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY INACTIVATED VACCINE, BY REGION, 2018-2027 (USD MILLION)
TABLE 17. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY SUBUNIT VACCINES, BY REGION, 2018-2027 (USD MILLION)
TABLE 18. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TOXOID VACCINES, BY REGION, 2018-2027 (USD MILLION)
TABLE 19. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2018-2027 (USD MILLION)
TABLE 20. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY HUMAN USE, BY REGION, 2018-2027 (USD MILLION)
TABLE 21. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY VETERINARY, BY REGION, 2018-2027 (USD MILLION)
TABLE 22. AMERICAS VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 23. ARGENTINA VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 24. BRAZIL VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 25. CANADA VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 26. MEXICO VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 27. UNITED STATES VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 28. ASIA-PACIFIC VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 29. AUSTRALIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 30. CHINA VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 31. INDIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 32. INDONESIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 33. JAPAN VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 34. MALAYSIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 35. PHILIPPINES VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 36. SINGAPORE VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 37. SOUTH KOREA VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 38. TAIWAN VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 39. THAILAND VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 40. EUROPE, MIDDLE EAST & AFRICA VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 41. FRANCE VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 42. GERMANY VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 43. ITALY VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 44. NETHERLANDS VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 45. QATAR VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 46. RUSSIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 47. SAUDI ARABIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 48. SOUTH AFRICA VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 49. SPAIN VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 50. UNITED ARAB EMIRATES VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 51. UNITED KINGDOM VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 52. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET: SCORES
TABLE 53. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET: BUSINESS STRATEGY
TABLE 54. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET: PRODUCT SATISFACTION
TABLE 55. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET: RANKING
TABLE 56. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 57. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET: MERGER & ACQUISITION
TABLE 58. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 59. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 60. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET: INVESTMENT & FUNDING
TABLE 61. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 62. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET: LICENSE & PRICING

Companies Mentioned

Ajinomoto Althea, Inc.
Albany Molecular Research, Inc.
Catalent, Inc.
Cobra Bio
Cytovance Biologics
FUJIFILM Diosynth Biotechnologies
GlaxoSmithKline PLC
ICON PLC
IDT Biologika
KBI Biopharma
LONZA
Merck KGaA
Paragon Bioservices, Inc.
Pfizer, Inc.
Pharmaceutical Product Development, LLC
PRA Health Sciences